Myriad Matters Blog

Nothing is more personal than an individual’s DNA fingerprint.  At Myriad, we honor our legal and ethical responsibility to protect patients’ genetic privacy.  In fact, our longstanding promise to millions of patients is to safeguard their genetic data by not selling or giving it away to any third parties, including public databases.  We believe that…

Myriad Genetics was proud to support Project BioEYES and help deliver STEM (science, technology, engineering, and mathematics) education to K-12 students throughout the Salt Lake City school district during the 2016-17 academic school year.  The local BioEYES program, which is led by the University of Utah’s Dr. Judith Neugebauer and John Anderson, taught more than…

June is Men’s Health Month and it’s important to help generate awareness on education for early detection of Men’s health issues, such as prostate cancer.  Prostate cancer is the most common cancer in Men, not including skin cancer. 1 of 7 men will be diagnosed with prostate cancer in his lifetime.  To help promote prostate cancer awareness, Myriad Genetics interviewed…

“I just could not get out of bed, no matter how hard I tried.”   Years ago, before taking the GeneSight test, Ronni went through a very traumatic experience in her life which resulted in an acute case of depression. Her depression was so severe, she could not get out of bed in the morning…

What is GeneSight? GeneSight Psychotropic is a laboratory developed genetic test that looks at many of the genes involved when your body processes certain types of medicines.  It is the only genetic test that provides this combined view to help your healthcare provider know which medicines may be a match for your genes. GeneSight gives…

Extract your own DNA at home! DNA, or Deoxyribonucleic acid, is the hereditary information in humans and most other plants and animals.  Nearly every cell in a person’s body has the same DNA.  It is made up of four chemical bases called adenine (A), cytosine (C), guanine (G), and thymine (T). Human DNA consists of…

Improving precision matters in prostate cancer    Understanding the risk of prostate cancer is very important for men ages 40 and older. Myriad Genetics created this infographic to answer a person’s four most pressing questions about prostate cancer. What are your risks of prostate cancer? Do you have prostate cancer? How aggressive is your prostate cancer?…

The strong culture of Myriad is a critical component of our company’s success.  Today, we are launching an Employee Spotlight!  It’s a way for Myriad to introduce the world to the wonderful people that make our company so fantastic. These Spotlights will be promoted via social media and will highlight several employees over time –…

Introducing a More Accurate Breast Cancer Diagnostic Test We are very excited to announce the launch of EndoPredict in the U.S.! This second-generation test provides more accurate 10-year recurrence risk for patients diagnosed with ER+ HER2- Early-Stage Breast Cancer. Read more here: https://myriad.com/investors/press-release-detail/?newsItemId=1017053 To learn more about EndoPredict, click here: http://endopredictusa.com/ EndoPredict’s accurate low-risk assessment can help…